Page last updated: 2024-10-24

busulfan and Aseptic Necrosis of Femur Head

busulfan has been researched along with Aseptic Necrosis of Femur Head in 1 studies

Research Excerpts

ExcerptRelevanceReference
"We report three patients with relapsed ovarian cancer who developed femoral head necrosis requiring endoprosthetic hip surgery 16-35 months after high-dose chemotherapy (HDC) with treosulfan (47 and 56 g/m(2) body-surface area (BSA)) given as 3-25 h infusions and followed by autologous peripheral blood stem cell (PBSC) transplantation."1.32Femoral head necrosis in three patients with relapsed ovarian cancer receiving high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation. ( Bojko, P; Dirsch, O; Hilger, RA; Ruehm, SG; Scheulen, ME; Seeber, S, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bojko, P1
Hilger, RA1
Ruehm, SG1
Dirsch, O1
Seeber, S1
Scheulen, ME1

Other Studies

1 other study available for busulfan and Aseptic Necrosis of Femur Head

ArticleYear
Femoral head necrosis in three patients with relapsed ovarian cancer receiving high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation.
    Bone marrow transplantation, 2003, Volume: 31, Issue:6

    Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Alkylating; Busulfan; Combined Modality Therapy; Femal

2003